Structure-intestinal permeability-relationship studies of backbone cyclic peptides: From model compounds to orally active drug lead

C. Gilon; Y. Linde; S. Hess; O. Ovadia; D. E. Shalev; H. Senderovich; T. Yehezkel; Y. Salitra; C. Haskel-Luevano; A. Hoffman

Structure-intestinal permeability-relationship studies of backbone cyclic peptides: From model compounds to orally active drug lead

C. Gilon
, Y. Linde
, S. Hess
, O. Ovadia
, D. E. Shalev
, H. Senderovich
, T. Yehezkel
, Y. Salitra
, C. Haskel-Luevano
, A. Hoffman

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	90-90
Number of pages	1
Journal	Journal of Peptide Science
Volume	12
State	Published - 2006

Cite this

@article{167568b9a45c4325b87ecb8532ecccd0,

title = "Structure-intestinal permeability-relationship studies of backbone cyclic peptides: From model compounds to orally active drug lead",

author = "C. Gilon and Y. Linde and S. Hess and O. Ovadia and Shalev, \{D. E.\} and H. Senderovich and T. Yehezkel and Y. Salitra and C. Haskel-Luevano and A. Hoffman",

year = "2006",

language = "אנגלית",

volume = "12",

pages = "90--90",

journal = "Journal of Peptide Science",

issn = "1075-2617",

publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Structure-intestinal permeability-relationship studies of backbone cyclic peptides

T2 - From model compounds to orally active drug lead

AU - Gilon, C.

AU - Linde, Y.

AU - Hess, S.

AU - Ovadia, O.

AU - Shalev, D. E.

AU - Senderovich, H.

AU - Yehezkel, T.

AU - Salitra, Y.

AU - Haskel-Luevano, C.

AU - Hoffman, A.

PY - 2006

Y1 - 2006

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=starter5-25&SrcAuth=WosAPI&KeyUT=WOS:000239905600032&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.abstract???

SN - 1075-2617

VL - 12

SP - 90

EP - 90

JO - Journal of Peptide Science

JF - Journal of Peptide Science

ER -

Structure-intestinal permeability-relationship studies of backbone cyclic peptides: From model compounds to orally active drug lead

Other files and links

Cite this